Document is current

Any future updates will be listed below

Author Correction: Targeting myeloid derived suppressor cells reverts immune suppression and sensitizes BRAF-mutant papillary thyroid cancer to MAPK inhibitors

Crossref DOI link: https://doi.org/10.1038/s41467-022-34545-6

Published Online: 2022-11-17

Update policy: https://doi.org/10.1007/springer_crossmark_policy

About CrossMark